| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.687 | 0.004 | 0.687 | Antihistaminic | 0.348 0.008 DBMET03763 | ||
| 0.685 | 0.004 | 0.685 | Histamine antagonist | 0.33 0.008 DBMET03763 | ||
| 0.687 | 0.012 | 0.687 | Antiobesity | 0.656 0.014 DBMET03763 | ||
| 0.603 | 0.003 | 0.603 | Histamine H3 receptor antagonist | 0.219 0.005 DBMET03763 | ||
| 0.612 | 0.025 | 0.612 | Analgesic | 0.54 0.039 DBMET03763 | ||
| 0.409 | 0.007 | 0.409 | Acetylcholine antagonist | 0.365 0.009 DBMET03763 | ||
| 0.408 | 0.007 | 0.408 | Cholinergic antagonist | 0.365 0.009 DBMET03763 | ||
| 0.411 | 0.026 | 0.411 | HERG channel blocker | 0.223 0.078 DBMET03763 | ||
| 0.389 | 0.005 | 0.389 | Histamine H1 receptor antagonist | 0.205 0.014 DBMET03763 | ||
| 0.378 | 0.007 | 0.378 | Acetylcholine M1 receptor antagonist | 0.35 0.009 DBMET03763 | ||
| 0.39 | 0.024 | 0.39 | Potassium channel blocker | 0.237 0.073 DBMET03763 | ||
| 0.388 | 0.024 | 0.388 | Sigma receptor agonist | 0.31 0.037 DBMET03763 | ||
| 0.368 | 0.006 | 0.368 | 5 Hydroxytryptamine agonist | 0.166 0.018 DBMET03763 | ||
| 0.339 | 0.005 | 0.339 | Chemokine receptor antagonist | 0.185 0.021 DBMET03763 | ||
| 0.351 | 0.036 | 0.351 | Potassium channel (Voltage-sensitive) blocker | 0.213 0.087 DBMET03763 | ||
| 0.316 | 0.008 | 0.316 | Acetylcholine muscarinic antagonist | 0.294 0.009 DBMET03763 | ||
| 0.287 | 0.005 | 0.287 | CC chemokine receptor antagonist | 0.15 0.018 DBMET03763 | ||
| 0.305 | 0.026 | 0.305 | 5 Hydroxytryptamine 1E antagonist | 0.208 0.122 DBMET03763 | ||
| 0.293 | 0.016 | 0.293 | Alpha adrenoreceptor antagonist | 0.143 0.039 DBMET03763 | ||
| 0.325 | 0.061 | 0.351 | Spasmolytic | 0.351 0.052 DBMET03763 | DBMET03763 | |
| 0.271 | 0.013 | 0.271 | Alpha 1 adrenoreceptor antagonist | 0.12 0.037 DBMET03763 | ||
| 0.262 | 0.003 | 0.262 | Phosphodiesterase 11A inhibitor | 0.216 0.004 DBMET03763 | ||
| 0.262 | 0.003 | 0.262 | Phosphodiesterase XI inhibitor | 0.216 0.004 DBMET03763 | ||
| 0.262 | 0.011 | 0.262 | Alpha 1a adrenoreceptor antagonist | 0.108 0.033 DBMET03763 | ||
| 0.271 | 0.022 | 0.271 | 5 Hydroxytryptamine antagonist | 0.102 0.077 DBMET03763 | ||
| 0.256 | 0.011 | 0.256 | Nav1.1 sodium channel blocker | 0.203 0.018 DBMET03763 | ||
| 0.244 | 0.009 | 0.244 | Acetylcholine agonist | 0.186 0.017 DBMET03763 | ||
| 0.298 | 0.075 | 0.396 | Interleukin 2 agonist | 0.396 0.029 DBMET03763 | DBMET03763 | |
| 0.217 | 0.005 | 0.217 | Acetylcholine M4 receptor antagonist | 0.115 0.019 DBMET03763 | ||
| 0.215 | 0.014 | 0.215 | 5 Hydroxytryptamine 1A antagonist | 0.07 0.046 DBMET03763 | ||
| 0.297 | 0.098 | 0.354 | Vasodilator, peripheral | 0.354 0.072 DBMET03763 | DBMET03763 | |
| 0.254 | 0.056 | 0.254 | Anticonvulsant | 0.18 0.099 DBMET03763 | ||
| 0.218 | 0.021 | 0.218 | Antiadrenergic | 0.142 0.038 DBMET03763 | ||
| 0.2 | 0.004 | 0.2 | CC chemokine 5 receptor antagonist | 0.14 0.005 DBMET03763 | ||
| 0.197 | 0.005 | 0.197 | Acetylcholine M5 receptor antagonist | 0.137 0.009 DBMET03763 | ||
| 0.212 | 0.021 | 0.212 | Adrenaline antagonist | 0.135 0.039 DBMET03763 | ||
| 0.225 | 0.036 | 0.225 | Diuretic | 0.207 0.042 DBMET03763 | ||
| 0.21 | 0.023 | 0.21 | Glutamate receptor antagonist | 0.163 0.043 DBMET03763 | ||
| 0.191 | 0.005 | 0.191 | Neurokinin antagonist | 0.134 0.006 DBMET03763 | ||
| 0.257 | 0.074 | 0.346 | Interleukin agonist | 0.346 0.03 DBMET03763 | DBMET03763 | |
| 0.238 | 0.056 | 0.381 | Anesthetic general | 0.381 0.019 DBMET03763 | DBMET03763 | |
| 0.218 | 0.038 | 0.218 | Antipruritic | 0.216 0.039 DBMET03763 | ||
| 0.183 | 0.004 | 0.183 | Neurokinin 2 antagonist | 0.142 0.006 DBMET03763 | ||
| 0.187 | 0.009 | 0.187 | Acetylcholine nicotinic agonist | 0.09 0.045 DBMET03763 | ||
| 0.259 | 0.085 | 0.259 | 5 Hydroxytryptamine release stimulant | 0.253 0.088 DBMET03763 | ||
| 0.29 | 0.121 | 0.424 | Immunosuppressant | 0.424 0.055 DBMET03763 | DBMET03763 | |
| 0.174 | 0.007 | 0.174 | 5 Hydroxytryptamine 3 antagonist | 0.057 0.039 DBMET03763 | ||
| 0.183 | 0.019 | 0.183 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.176 | 0.014 | 0.176 | Prolactin inhibitor | 0.156 0.02 DBMET03763 | ||
| 0.209 | 0.05 | 0.209 | Anticoagulant | 0.177 0.063 DBMET03763 | ||
| 0.188 | 0.029 | 0.188 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.165 | 0.009 | 0.165 | Acetylcholine muscarinic agonist | 0.132 0.012 DBMET03763 | ||
| 0.172 | 0.018 | 0.172 | Alpha 1b adrenoreceptor antagonist | 0.067 0.055 DBMET03763 | ||
| 0.273 | 0.12 | 0.307 | Calcium channel activator | 0.307 0.085 DBMET03763 | DBMET03763 | |
| 0.163 | 0.013 | 0.163 | Acetylcholine M3 receptor agonist | 0.157 0.016 DBMET03763 | ||
| 0.184 | 0.035 | 0.207 | Neurotrophic factor | 0.207 0.025 DBMET03763 | DBMET03763 | |
| 0.147 | 0.005 | 0.147 | Glutamate (mGluR group I) agonist | 0.062 0.021 DBMET03763 | ||
| 0.175 | 0.034 | 0.175 | Nav1.3 sodium channel blocker | |||
| 0.248 | 0.11 | 0.248 | Nootropic | 0.193 0.168 DBMET03763 | ||
| 0.138 | 0.005 | 0.138 | 5 Hydroxytryptamine 2C agonist | 0.086 0.01 DBMET03763 | ||
| 0.226 | 0.095 | 0.226 | Tyrosine 3 hydroxylase inhibitor | 0.185 0.165 DBMET03763 | ||
| 0.135 | 0.004 | 0.135 | Neurokinin 3 antagonist | 0.091 0.007 DBMET03763 | ||
| 0.135 | 0.005 | 0.135 | Neurokinin 1 antagonist | 0.096 0.007 DBMET03763 | ||
| 0.179 | 0.05 | 0.227 | NOS3 expression enhancer | 0.227 0.032 DBMET03763 | DBMET03763 | |
| 0.153 | 0.031 | 0.153 | Alpha 2c adrenoreceptor antagonist | 0.101 0.065 DBMET03763 | ||
| 0.126 | 0.005 | 0.126 | Glutamate (mGluR5) agonist | 0.059 0.018 DBMET03763 | ||
| 0.137 | 0.017 | 0.137 | Cannabinoid receptor antagonist | |||
| 0.126 | 0.008 | 0.126 | Nicotinic neuronal receptor agonist | |||
| 0.153 | 0.036 | 0.153 | Calcium channel N-type blocker | |||
| 0.118 | 0.006 | 0.118 | Dipeptidyl peptidase inhibitor | 0.059 0.027 DBMET03763 | ||
| 0.134 | 0.023 | 0.134 | Thioredoxin inhibitor | 0.121 0.03 DBMET03763 | ||
| 0.148 | 0.039 | 0.148 | Alpha 2b adrenoreceptor antagonist | |||
| 0.228 | 0.119 | 0.228 | Insulysin inhibitor | |||
| 0.112 | 0.005 | 0.112 | Acetylcholine M2 receptor agonist | 0.101 0.007 DBMET03763 | ||
| 0.137 | 0.031 | 0.137 | Alpha 2 adrenoreceptor antagonist | 0.085 0.06 DBMET03763 | ||
| 0.109 | 0.005 | 0.109 | Dipeptidyl peptidase IV inhibitor | 0.052 0.019 DBMET03763 | ||
| 0.208 | 0.106 | 0.208 | Neuropeptide Y2 antagonist | |||
| 0.129 | 0.027 | 0.129 | Acetylcholine nicotinic antagonist | 0.093 0.044 DBMET03763 | ||
| 0.23 | 0.132 | 0.347 | Immunomodulator | 0.347 0.061 DBMET03763 | DBMET03763 | |
| 0.111 | 0.013 | 0.111 | CC chemokine 5 receptor agonist | 0.086 0.047 DBMET03763 | ||
| 0.126 | 0.028 | 0.126 | Alpha 2a adrenoreceptor antagonist | |||
| 0.112 | 0.015 | 0.192 | Glycine receptor agonist | 0.192 0.004 DBMET03763 | DBMET03763 | |
| 0.114 | 0.018 | 0.114 | Acetylcholine M2 receptor antagonist | 0.083 0.027 DBMET03763 | ||
| 0.121 | 0.026 | 0.121 | Glutamate receptor agonist | |||
| 0.103 | 0.008 | 0.103 | Potassium channel (Tandem pore domain) blocker | 0.083 0.028 DBMET03763 | ||
| 0.142 | 0.047 | 0.142 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.115 | 0.021 | 0.115 | Phosphodiesterase V inhibitor | 0.086 0.035 DBMET03763 | ||
| 0.305 | 0.211 | 0.477 | Antiinflammatory | 0.477 0.098 DBMET03763 | DBMET03763 | |
| 0.096 | 0.005 | 0.096 | Prolactin release inhibitor | 0.09 0.006 DBMET03763 | ||
| 0.121 | 0.03 | 0.124 | Glutamate (mGluR7) agonist | 0.124 0.026 DBMET03763 | DBMET03763 | |
| 0.1 | 0.009 | 0.1 | 5 Hydroxytryptamine 2 agonist | 0.059 0.028 DBMET03763 | ||
| 0.102 | 0.013 | 0.102 | CC chemokine 2 receptor antagonist | 0.072 0.023 DBMET03763 | ||
| 0.098 | 0.009 | 0.098 | Purinergic P2X antagonist | 0.045 0.038 DBMET03763 | ||
| 0.108 | 0.021 | 0.108 | Neuronal nicotinic receptor antagonist | 0.076 0.04 DBMET03763 | ||
| 0.103 | 0.017 | 0.105 | Acetylcholine M3 receptor antagonist | 0.105 0.017 DBMET03763 | DBMET03763 | |
| 0.096 | 0.012 | 0.098 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.098 0.012 DBMET03763 | DBMET03763 | |
| 0.086 | 0.003 | 0.086 | Nicotinic alpha3beta4 receptor agonist | 0.057 0.004 DBMET03763 | ||
| 0.089 | 0.007 | 0.089 | Factor XIa inhibitor | 0.049 0.019 DBMET03763 | ||
| 0.101 | 0.019 | 0.101 | Acetylcholine M5 receptor agonist | 0.085 0.03 DBMET03763 | ||
| 0.102 | 0.021 | 0.102 | Purinergic P2 antagonist | 0.055 0.054 DBMET03763 | ||
| 0.129 | 0.048 | 0.129 | 5 Hydroxytryptamine 3A agonist | |||
| 0.089 | 0.009 | 0.089 | Poly(ADP-ribose) polymerase inhibitor | 0.043 0.034 DBMET03763 | ||
| 0.104 | 0.025 | 0.104 | Phosphodiesterase 5A inhibitor | 0.079 0.04 DBMET03763 | ||
| 0.087 | 0.009 | 0.087 | Prolyl endopeptidase inhibitor | 0.063 0.021 DBMET03763 | ||
| 0.085 | 0.009 | 0.085 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.035 0.03 DBMET03763 | ||
| 0.094 | 0.017 | 0.094 | Orexin receptor 1 antagonist | |||
| 0.083 | 0.007 | 0.083 | Acetyl-CoA carboxylase inhibitor | 0.07 0.011 DBMET03763 | ||
| 0.106 | 0.03 | 0.106 | Opioid kappa receptor antagonist | 0.098 0.037 DBMET03763 | ||
| 0.08 | 0.005 | 0.08 | Purinergic P2X7 antagonist | 0.042 0.02 DBMET03763 | ||
| 0.1 | 0.026 | 0.1 | Glutamate (mGluR group I) antagonist | |||
| 0.228 | 0.156 | 0.269 | Vasodilator, coronary | 0.269 0.115 DBMET03763 | DBMET03763 | |
| 0.089 | 0.019 | 0.089 | Orexin receptor antagonist | |||
| 0.085 | 0.015 | 0.085 | Glycine transporter inhibitor | |||
| 0.089 | 0.021 | 0.089 | Cannabinoid CB1 receptor antagonist | |||
| 0.086 | 0.018 | 0.086 | Melanin-concentrating hormone receptor 1 antagonist | 0.047 0.045 DBMET03763 | ||
| 0.109 | 0.042 | 0.109 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.109 | 0.044 | 0.109 | mTOR complex 1 inhibitor | 0.108 0.047 DBMET03763 | ||
| 0.221 | 0.155 | 0.309 | Apoptosis antagonist | 0.309 0.08 DBMET03763 | DBMET03763 | |
| 0.089 | 0.023 | 0.089 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.145 | 0.081 | 0.145 | Cholinergic | |||
| 0.082 | 0.018 | 0.082 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.092 | 0.03 | 0.092 | Viral attachment inhibitor | |||
| 0.079 | 0.019 | 0.079 | Fatty acid synthase inhibitor | 0.067 0.028 DBMET03763 | ||
| 0.083 | 0.023 | 0.083 | Phosphodiesterase VII inhibitor | 0.072 0.033 DBMET03763 | ||
| 0.204 | 0.145 | 0.204 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.096 | 0.038 | 0.096 | mTOR complex 2 inhibitor | 0.089 0.05 DBMET03763 | ||
| 0.08 | 0.023 | 0.08 | Alpha 1 adrenoreceptor agonist | |||
| 0.139 | 0.082 | 0.143 | Hemostatic | 0.143 0.077 DBMET03763 | DBMET03763 | |
| 0.093 | 0.037 | 0.093 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.062 | 0.007 | 0.062 | CXC chemokine 3 receptor antagonist | 0.031 0.022 DBMET03763 | ||
| 0.073 | 0.018 | 0.073 | Acetylcholine M1 receptor agonist | 0.05 0.026 DBMET03763 | ||
| 0.062 | 0.007 | 0.062 | Phosphodiesterase 6C inhibitor | 0.054 0.014 DBMET03763 | ||
| 0.067 | 0.013 | 0.067 | Kinesin antagonist | |||
| 0.067 | 0.013 | 0.067 | Kinesin-like protein 1 inhibitor | |||
| 0.09 | 0.037 | 0.09 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.108 | 0.055 | 0.171 | Bronchodilator | 0.171 0.024 DBMET03763 | DBMET03763 | |
| 0.093 | 0.039 | 0.093 | Glutamate (mGluR) antagonist | |||
| 0.083 | 0.031 | 0.083 | Dopamine D1 antagonist | |||
| 0.082 | 0.03 | 0.082 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.066 | 0.014 | 0.066 | Phosphodiesterase 7A inhibitor | 0.061 0.02 DBMET03763 | ||
| 0.067 | 0.018 | 0.067 | Glutamate (mGluR5) antagonist | |||
| 0.052 | 0.004 | 0.052 | Nicotinic alpha4beta2 receptor agonist | 0.026 0.024 DBMET03763 | ||
| 0.075 | 0.027 | 0.075 | Dopamine uptake inhibitor | 0.067 0.032 DBMET03763 | ||
| 0.063 | 0.016 | 0.063 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.056 | 0.01 | 0.056 | Acetylcholine M4 receptor agonist | 0.039 0.015 DBMET03763 | ||
| 0.096 | 0.05 | 0.096 | NMDA receptor antagonist | 0.08 0.066 DBMET03763 | ||
| 0.064 | 0.018 | 0.064 | Antidiuretic hormone antagonist | |||
| 0.082 | 0.036 | 0.082 | Toll-Like receptor 7 antagonist | |||
| 0.071 | 0.026 | 0.071 | Potassium channel (Ca-activated) blocker | |||
| 0.081 | 0.036 | 0.081 | CXC chemokine receptor antagonist | |||
| 0.052 | 0.007 | 0.052 | Phosphodiesterase 6B inhibitor | 0.039 0.012 DBMET03763 | ||
| 0.253 | 0.209 | 0.402 | Cyclophilin D inhibitor | 0.402 0.09 DBMET03763 | DBMET03763 | |
| 0.049 | 0.007 | 0.049 | Acetyl-CoA carboxylase 2 inhibitor | 0.032 0.011 DBMET03763 | ||
| 0.056 | 0.014 | 0.056 | Substance P antagonist | 0.043 0.023 DBMET03763 | ||
| 0.054 | 0.012 | 0.054 | Vasopressin 1A antagonist | |||
| 0.09 | 0.049 | 0.09 | Hematopoietic | 0.089 0.051 DBMET03763 | ||
| 0.064 | 0.025 | 0.064 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.049 | 0.012 | 0.068 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.068 0.005 DBMET03763 | DBMET03763 | |
| 0.072 | 0.035 | 0.072 | 5 Hydroxytryptamine 2A agonist | |||
| 0.132 | 0.095 | 0.144 | Pregnane X receptor agonist | 0.144 0.064 DBMET03763 | DBMET03763 | |
| 0.051 | 0.015 | 0.051 | Glycine transporter 1 inhibitor | |||
| 0.081 | 0.047 | 0.081 | Dopamine antagonist | |||
| 0.044 | 0.01 | 0.044 | Complement C5a chemotactic receptor antagonist | 0.029 0.022 DBMET03763 | ||
| 0.049 | 0.015 | 0.049 | Vasopressin 1 antagonist | |||
| 0.056 | 0.023 | 0.056 | Aldosterone antagonist | 0.053 0.025 DBMET03763 | ||
| 0.068 | 0.035 | 0.068 | NMDA 2C receptor antagonist | |||
| 0.09 | 0.057 | 0.09 | Opioid antagonist | 0.083 0.066 DBMET03763 | ||
| 0.056 | 0.023 | 0.056 | Histamine H4 receptor antagonist | |||
| 0.055 | 0.023 | 0.055 | Farnesyltransferase inhibitor | |||
| 0.074 | 0.043 | 0.074 | Alpha adrenoreceptor agonist | |||
| 0.072 | 0.043 | 0.072 | Dopamine D2 antagonist | |||
| 0.033 | 0.004 | 0.033 | Nicotinic alpha4 receptor agonist | |||
| 0.054 | 0.027 | 0.054 | Factor Xa inhibitor | |||
| 0.048 | 0.021 | 0.048 | Nerve growth factor antagonist | |||
| 0.066 | 0.039 | 0.066 | Adrenaline uptake inhibitor | |||
| 0.032 | 0.006 | 0.032 | Phosphodiesterase 6H inhibitor | 0.026 0.013 DBMET03763 | ||
| 0.032 | 0.006 | 0.032 | Phosphodiesterase 6G inhibitor | 0.026 0.013 DBMET03763 | ||
| 0.066 | 0.04 | 0.066 | Glutamate (mGluR) agonist | |||
| 0.062 | 0.037 | 0.062 | Glutamate (mGluR1) antagonist | |||
| 0.044 | 0.019 | 0.044 | 5 Hydroxytryptamine 2B agonist | |||
| 0.042 | 0.017 | 0.042 | Vasopressin 2 antagonist | |||
| 0.058 | 0.033 | 0.058 | Nicotinic alpha7 receptor agonist | |||
| 0.048 | 0.023 | 0.048 | Guanylate cyclase inhibitor | 0.047 0.024 DBMET03763 | ||
| 0.035 | 0.013 | 0.037 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.037 0.012 DBMET03763 | DBMET03763 | |
| 0.041 | 0.02 | 0.041 | Orexin receptor 2 antagonist | |||
| 0.261 | 0.24 | 0.328 | Caspase 9 stimulant | 0.328 0.165 DBMET03763 | DBMET03763 | |
| 0.024 | 0.005 | 0.024 | CXC chemokine 5 receptor antagonist | |||
| 0.037 | 0.018 | 0.037 | ADAM10 endopeptidase inhibitor | 0.034 0.022 DBMET03763 | ||
| 0.033 | 0.014 | 0.033 | Potassium channel (Inward rectifier) 1 blocker | 0.031 0.018 DBMET03763 | ||
| 0.082 | 0.063 | 0.107 | Antineoplastic alkaloid | 0.107 0.044 DBMET03763 | DBMET03763 | |
| 0.144 | 0.126 | 0.167 | P-glycoprotein inhibitor | 0.167 0.094 DBMET03763 | DBMET03763 | |
| 0.195 | 0.177 | 0.264 | Caspase 3 stimulant | 0.264 0.101 DBMET03763 | DBMET03763 | |
| 0.093 | 0.075 | 0.093 | GABA C receptor agonist | |||
| 0.045 | 0.029 | 0.045 | Dopamine D5 antagonist | |||
| 0.033 | 0.019 | 0.033 | Potassium channel subfamily K member 3 blocker | |||
| 0.043 | 0.03 | 0.047 | Opioid kappa receptor agonist | 0.047 0.026 DBMET03763 | DBMET03763 | |
| 0.139 | 0.126 | 0.139 | Psychostimulant | 0.138 0.128 DBMET03763 | ||
| 0.036 | 0.024 | 0.036 | p53 inhibitor | |||
| 0.029 | 0.019 | 0.029 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.058 | 0.048 | 0.058 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.07 | 0.061 | 0.07 | Analgesic, opioid | 0.067 0.066 DBMET03763 | ||
| 0.014 | 0.006 | 0.014 | Melatonin 2 antagonist | |||
| 0.104 | 0.096 | 0.16 | Alpha-N-acetylglucosaminidase inhibitor | 0.16 0.05 DBMET03763 | DBMET03763 | |
| 0.064 | 0.057 | 0.064 | NMDA 2 receptor antagonist | |||
| 0.048 | 0.041 | 0.048 | Factor III inhibitor | |||
| 0.107 | 0.1 | 0.107 | Nav1.2 sodium channel blocker | |||
| 0.048 | 0.042 | 0.048 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.036 | 0.03 | 0.036 | Oxytocin antagonist | |||
| 0.074 | 0.068 | 0.074 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.034 | 0.028 | 0.034 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.041 | 0.036 | 0.041 | 5 Hydroxytryptamine 1A agonist | |||
| 0.032 | 0.027 | 0.032 | Factor XI inhibitor | |||
| 0.046 | 0.042 | 0.046 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.04 | 0.036 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.049 | 0.045 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.022 | 0.019 | 0.022 | Phosphodiesterase 6A inhibitor | |||
| 0.026 | 0.023 | 0.026 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.01 | 0.009 | 0.012 | Calcineurin inhibitor | 0.012 0.007 DBMET03763 | DBMET03763 | |
| 0.058 | 0.057 | 0.058 | Opioid mu receptor antagonist | |||
| 0.043 | 0.042 | 0.043 | 5 Hydroxytryptamine 1 agonist | |||
| 0.033 | 0.032 | 0.033 | Adenosine uptake inhibitor | |||
| 0.194 | 0.196 | 0.358 | Sodium/bile acid cotransporter inhibitor | 0.358 0.035 DBMET03763 | DBMET03763 | |
| 0.04 | 0.044 | 0.054 | Adenylate cyclase 1 inhibitor | 0.054 0.023 DBMET03763 | DBMET03763 | |
| 0.137 | 0.151 | 0.275 | Hypolipemic | 0.275 0.057 DBMET03763 | DBMET03763 | |
| 0.182 | 0.201 | 0.24 | Antithrombotic | 0.24 0.134 DBMET03763 | DBMET03763 | |
| 0.106 | 0.125 | 0.116 | Cell wall synthesis inhibitor | 0.116 0.106 DBMET03763 | DBMET03763 | |
| 0.056 | 0.075 | 0.101 | MAP kinase kinase 8 inhibitor | 0.101 0.022 DBMET03763 | DBMET03763 | |
| 0.046 | 0.066 | 0.092 | Androgen agonist | 0.092 0.018 DBMET03763 | DBMET03763 | |
| 0.064 | 0.088 | 0.092 | Glycine receptor antagonist | 0.092 0.041 DBMET03763 | DBMET03763 | |
| 0.021 | 0.048 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 DBMET03763 | DBMET03763 | |
| 0.134 | 0.164 | 0.186 | Platelet antagonist | 0.186 0.112 DBMET03763 | DBMET03763 | |
| 0.124 | 0.157 | 0.132 | Ca2+-transporting ATPase inhibitor | 0.132 0.107 DBMET03763 | DBMET03763 | |
| 0.128 | 0.161 | 0.187 | Phospholipase C inhibitor | 0.187 0.054 DBMET03763 | DBMET03763 | |
| 0.105 | 0.165 | 0.141 | Adenylate cyclase stimulant | 0.141 0.079 DBMET03763 | DBMET03763 | |
| 0.06 | 0.134 | 0.074 | MAP kinase kinase 7 inhibitor | 0.074 0.067 DBMET03763 | DBMET03763 | |
| 0.064 | 0.144 | 0.101 | Bile acid receptor antagonist | 0.101 0.047 DBMET03763 | DBMET03763 | |
| 0.069 | 0.158 | 0.099 | Microtubule formation inhibitor | 0.099 0.093 DBMET03763 | DBMET03763 | |
| 0.139 | 0.229 | 0.222 | DNA synthesis inhibitor | 0.222 0.092 DBMET03763 | DBMET03763 | |
| 0.059 | 0.167 | 0.114 | Adenylate cyclase inhibitor | 0.114 0.073 DBMET03763 | DBMET03763 | |
| 0.053 | 0.18 | 0.092 | Anabolic | 0.092 0.075 DBMET03763 | DBMET03763 | |
| 0.092 | 0.231 | 0.131 | Interferon gamma antagonist | 0.131 0.109 DBMET03763 | DBMET03763 | |
| 0.072 | 0.211 | 0.111 | Protein kinase stimulant | 0.111 0.103 DBMET03763 | DBMET03763 | |
| 0.081 | 0.262 | 0.166 | Immunostimulant | 0.166 0.142 DBMET03763 | DBMET03763 | |
| 0.08 | 0.287 | 0.191 | Tumour necrosis factor alpha release inhibitor | 0.191 0.117 DBMET03763 | DBMET03763 | |
| 0.004 | 0.225 | 0.028 | RNA-directed RNA polymerase stimulant | 0.028 0.022 DBMET03763 | DBMET03763 | |
| 0.116 | 0.347 | 0.211 | Toll-Like receptor 7 agonist | 0.211 0.188 DBMET03763 | DBMET03763 | |
| 0.082 | 0.326 | 0.161 | Lipocortins synthesis antagonist | 0.161 0.091 DBMET03763 | DBMET03763 | |
| 0.108 | 0.365 | 0.201 | Toll-Like receptor agonist | 0.201 0.2 DBMET03763 | DBMET03763 | |
| 0.019 | 0.294 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.027 DBMET03763 | DBMET03763 | |
| 0.054 | 0.341 | 0.126 | Nitric oxide antagonist | 0.126 0.125 DBMET03763 | DBMET03763 | |
| 0.057 | 0.37 | 0.145 | Hepatoprotectant | 0.145 0.115 DBMET03763 | DBMET03763 | |
| 0.103 | 0.465 | 0.259 | Apoptosis agonist | 0.259 0.205 DBMET03763 | DBMET03763 | |
| 0.04 | 0.406 | 0.117 | Farnesoid X receptor antagonist | 0.117 0.111 DBMET03763 | DBMET03763 | |
| 0.065 | 0.759 | 0.186 | Peptidyltransferase inhibitor | 0.186 0.119 DBMET03763 | DBMET03763 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |